Cargando…

Lipases and lipid droplet-associated protein expression in subcutaneous white adipose tissue of cachectic patients with cancer

BACKGROUND: Cancer cachexia is a multifactorial metabolic syndrome characterized by marked loss of adipose tissue and skeletal muscle. Fat loss from adipose tissue in cancer cachexia is partly the result of increased lipolysis. Despite the growing amount of studies focused on elucidating the mechani...

Descripción completa

Detalles Bibliográficos
Autores principales: Silvério, Renata, Lira, Fábio S., Oyama, Lila M., Oller do Nascimento, Cláudia M., Otoch, José P., Alcântara, Paulo S. M., Batista, Miguel L., Seelaender, Marília
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5568087/
https://www.ncbi.nlm.nih.gov/pubmed/28830524
http://dx.doi.org/10.1186/s12944-017-0547-x
_version_ 1783258798374256640
author Silvério, Renata
Lira, Fábio S.
Oyama, Lila M.
Oller do Nascimento, Cláudia M.
Otoch, José P.
Alcântara, Paulo S. M.
Batista, Miguel L.
Seelaender, Marília
author_facet Silvério, Renata
Lira, Fábio S.
Oyama, Lila M.
Oller do Nascimento, Cláudia M.
Otoch, José P.
Alcântara, Paulo S. M.
Batista, Miguel L.
Seelaender, Marília
author_sort Silvério, Renata
collection PubMed
description BACKGROUND: Cancer cachexia is a multifactorial metabolic syndrome characterized by marked loss of adipose tissue and skeletal muscle. Fat loss from adipose tissue in cancer cachexia is partly the result of increased lipolysis. Despite the growing amount of studies focused on elucidating the mechanisms through which lipolysis-related proteins regulate the lipolytic process, there are scarce data concerning that profile in the adipose tissue of cancer cachectic patients. Considering its fundamental importance, it was our main purpose to characterize the expression of the lipolysis-related proteins in the white adipose tissue of cachectic cancer patients. METHODS: Patients from the University Hospital were divided into three groups: control, cancer cachexia (CC), and weight-stable cancer patients (WSC). To gain greater insight into adipose tissue wasting during cancer cachexia progression, we have also analyzed an experimental model of cachexia (Walker 256 carcinosarcoma). Animals were divided into: control, intermediate cachexia (IC) and terminal cachexia (TC). Subcutaneous white adipose tissue of patients and epidydimal white adipose tissue of animals were investigated regarding molecular aspects by determining the protein content and gene expression of hormone-sensitive lipase (HSL), adipose triglyceride lipase (ATGL), comparative gene identification-58 (CGI-58), perilipin 1, leptin, adiponectin, visfatin, and tumour necrosis factor alpha (TNF-alpha). RESULTS: We found augmented lipolysis in CC associated with increased HSL expression, as well as upregulation of ATGL expression and reduction in perilipin 1 content. In IC, there was an imbalance in the secretion of pro- and anti-inflammatory factors. The alterations at the end-stage of cachexia were even more profound, and there was a reduction in the expression of almost all proteins analyzed in the animals. CONCLUSIONS: Our findings show that cachexia induces important morphological, molecular, and humoral alterations in the white adipose tissue, which are specific to the stage of the syndrome.
format Online
Article
Text
id pubmed-5568087
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-55680872017-08-29 Lipases and lipid droplet-associated protein expression in subcutaneous white adipose tissue of cachectic patients with cancer Silvério, Renata Lira, Fábio S. Oyama, Lila M. Oller do Nascimento, Cláudia M. Otoch, José P. Alcântara, Paulo S. M. Batista, Miguel L. Seelaender, Marília Lipids Health Dis Research BACKGROUND: Cancer cachexia is a multifactorial metabolic syndrome characterized by marked loss of adipose tissue and skeletal muscle. Fat loss from adipose tissue in cancer cachexia is partly the result of increased lipolysis. Despite the growing amount of studies focused on elucidating the mechanisms through which lipolysis-related proteins regulate the lipolytic process, there are scarce data concerning that profile in the adipose tissue of cancer cachectic patients. Considering its fundamental importance, it was our main purpose to characterize the expression of the lipolysis-related proteins in the white adipose tissue of cachectic cancer patients. METHODS: Patients from the University Hospital were divided into three groups: control, cancer cachexia (CC), and weight-stable cancer patients (WSC). To gain greater insight into adipose tissue wasting during cancer cachexia progression, we have also analyzed an experimental model of cachexia (Walker 256 carcinosarcoma). Animals were divided into: control, intermediate cachexia (IC) and terminal cachexia (TC). Subcutaneous white adipose tissue of patients and epidydimal white adipose tissue of animals were investigated regarding molecular aspects by determining the protein content and gene expression of hormone-sensitive lipase (HSL), adipose triglyceride lipase (ATGL), comparative gene identification-58 (CGI-58), perilipin 1, leptin, adiponectin, visfatin, and tumour necrosis factor alpha (TNF-alpha). RESULTS: We found augmented lipolysis in CC associated with increased HSL expression, as well as upregulation of ATGL expression and reduction in perilipin 1 content. In IC, there was an imbalance in the secretion of pro- and anti-inflammatory factors. The alterations at the end-stage of cachexia were even more profound, and there was a reduction in the expression of almost all proteins analyzed in the animals. CONCLUSIONS: Our findings show that cachexia induces important morphological, molecular, and humoral alterations in the white adipose tissue, which are specific to the stage of the syndrome. BioMed Central 2017-08-22 /pmc/articles/PMC5568087/ /pubmed/28830524 http://dx.doi.org/10.1186/s12944-017-0547-x Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Silvério, Renata
Lira, Fábio S.
Oyama, Lila M.
Oller do Nascimento, Cláudia M.
Otoch, José P.
Alcântara, Paulo S. M.
Batista, Miguel L.
Seelaender, Marília
Lipases and lipid droplet-associated protein expression in subcutaneous white adipose tissue of cachectic patients with cancer
title Lipases and lipid droplet-associated protein expression in subcutaneous white adipose tissue of cachectic patients with cancer
title_full Lipases and lipid droplet-associated protein expression in subcutaneous white adipose tissue of cachectic patients with cancer
title_fullStr Lipases and lipid droplet-associated protein expression in subcutaneous white adipose tissue of cachectic patients with cancer
title_full_unstemmed Lipases and lipid droplet-associated protein expression in subcutaneous white adipose tissue of cachectic patients with cancer
title_short Lipases and lipid droplet-associated protein expression in subcutaneous white adipose tissue of cachectic patients with cancer
title_sort lipases and lipid droplet-associated protein expression in subcutaneous white adipose tissue of cachectic patients with cancer
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5568087/
https://www.ncbi.nlm.nih.gov/pubmed/28830524
http://dx.doi.org/10.1186/s12944-017-0547-x
work_keys_str_mv AT silveriorenata lipasesandlipiddropletassociatedproteinexpressioninsubcutaneouswhiteadiposetissueofcachecticpatientswithcancer
AT lirafabios lipasesandlipiddropletassociatedproteinexpressioninsubcutaneouswhiteadiposetissueofcachecticpatientswithcancer
AT oyamalilam lipasesandlipiddropletassociatedproteinexpressioninsubcutaneouswhiteadiposetissueofcachecticpatientswithcancer
AT ollerdonascimentoclaudiam lipasesandlipiddropletassociatedproteinexpressioninsubcutaneouswhiteadiposetissueofcachecticpatientswithcancer
AT otochjosep lipasesandlipiddropletassociatedproteinexpressioninsubcutaneouswhiteadiposetissueofcachecticpatientswithcancer
AT alcantarapaulosm lipasesandlipiddropletassociatedproteinexpressioninsubcutaneouswhiteadiposetissueofcachecticpatientswithcancer
AT batistamiguell lipasesandlipiddropletassociatedproteinexpressioninsubcutaneouswhiteadiposetissueofcachecticpatientswithcancer
AT seelaendermarilia lipasesandlipiddropletassociatedproteinexpressioninsubcutaneouswhiteadiposetissueofcachecticpatientswithcancer